uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Endocrine ophthalmopathy and radioiodine therapy
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences. (Endokrinologi och diabetes)
2006 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 45, no 8, 1046-1050 p.Article in journal (Refereed) Published
Abstract [en]

Endocrine ophthalmopathy is to some degree present in most patients with Graves' disease. In few cases, a severe form of the condition develops and in the majority of these cases, the course of the eye problems has been influenced by the treatment for thyrotoxicosis. In this regard, radioiodine therapy has been increasingly recognized as carrying a special risk. Here, the current understanding of endocrine ophthalmopathy and the risks associated with the development of severe eye disease are discussed. The results of a retrospective investigation of patients with severe eye disease in our hospital, and the experience with corticosteroid administration following radioiodine in order to reduce the risk of ophthalmopathy, are also presented.

Place, publisher, year, edition, pages
2006. Vol. 45, no 8, 1046-1050 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-124776DOI: 10.1080/02841860600760769ISI: 000242213300007PubMedID: 17118837OAI: oai:DiVA.org:uu-124776DiVA: diva2:317952
Available from: 2010-05-05 Created: 2010-05-05 Last updated: 2011-05-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Medical Sciences
In the same journal
Acta Oncologica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 155 hits
ReferencesLink to record
Permanent link

Direct link